Search

everythinglearnresearchcommunity

for

Search:↓

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.

Nourkrin® significantly increased hair growth and was well-tolerated by people with hair loss.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.

Melatonin increases cashmere quality in goats but reduces their milk production and doesn't affect their offspring's hair growth.

Balding and low testosterone increase risk of urinary stones.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Finasteride increases risk of sleep apnea and insomnia.

PCOS increases sexual pain distress in infertile women.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Finasteride use linked to increased suicidality in patients under 45.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

PCOD increases weight but keeps BMI normal in young women.

The visfatin GT genotype may increase the risk of Alopecia Areata.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Androgens can both increase body hair and cause scalp hair loss.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Androgens can both increase and decrease hair growth in different parts of the body.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Laser device increases hair density, safe for treating hair loss in men and women.